ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $545,783 | -28.6% | 20,312 | -5.3% | 0.02% | -31.0% |
| Q2 2023 | $764,550 | -50.3% | 21,440 | -64.6% | 0.03% | -54.7% |
| Q1 2023 | $1,538,072 | +45.2% | 60,554 | +162.9% | 0.06% | +56.1% |
| Q1 2022 | $1,059,000 | +203.4% | 23,030 | +337.8% | 0.04% | +156.2% |
| Q4 2021 | $349,000 | -36.8% | 5,260 | -40.6% | 0.02% | -48.4% |
| Q3 2021 | $552,000 | +42.6% | 8,848 | +89.5% | 0.03% | +24.0% |
| Q2 2021 | $387,000 | -82.5% | 4,670 | -86.6% | 0.02% | -74.2% |
| Q4 2019 | $2,212,000 | +366.7% | 34,875 | +107.6% | 0.10% | +304.2% |
| Q3 2019 | $474,000 | -72.4% | 16,803 | -74.0% | 0.02% | -74.7% |
| Q2 2019 | $1,715,000 | +499.7% | 64,731 | +315.0% | 0.10% | +458.8% |
| Q1 2019 | $286,000 | – | 15,597 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |